BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 31396023)

  • 1. Diffusion Kurtosis MR Imaging versus Conventional Diffusion-Weighted Imaging for Distinguishing Hepatocellular Carcinoma from Benign Hepatic Nodules.
    Jia Y; Cai H; Wang M; Luo Y; Xu L; Dong Z; Yan X; Li ZP; Feng ST
    Contrast Media Mol Imaging; 2019; 2019():2030147. PubMed ID: 31396023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
    Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
    J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions.
    Vossen JA; Buijs M; Liapi E; Eng J; Bluemke DA; Kamel IR
    J Comput Assist Tomogr; 2008; 32(5):750-6. PubMed ID: 18830105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis.
    Agnello F; Ronot M; Valla DC; Sinkus R; Van Beers BE; Vilgrain V
    Radiology; 2012 Feb; 262(2):511-9. PubMed ID: 22143926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IVIM-diffusion-MRI for the differentiation of solid benign and malign hypervascular liver lesions-Evaluation with two different MR scanners.
    Klauss M; Mayer P; Maier-Hein K; Laun FB; Mehrabi A; Kauczor HU; Stieltjes B
    Eur J Radiol; 2016 Jul; 85(7):1289-94. PubMed ID: 27235876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating between malignant and benign solid solitary pulmonary lesions: are intravoxel incoherent motion and diffusion kurtosis imaging superior to conventional diffusion-weighted imaging?
    Wan Q; Deng YS; Lei Q; Bao YY; Wang YZ; Zhou JX; Zou Q; Li XC
    Eur Radiol; 2019 Mar; 29(3):1607-1615. PubMed ID: 30255258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion kurtosis imaging of the liver at 3 Tesla: in vivo comparison to standard diffusion-weighted imaging.
    Budjan J; Sauter EA; Zoellner FG; Lemke A; Wambsganss J; Schoenberg SO; Attenberger UI
    Acta Radiol; 2018 Jan; 59(1):18-25. PubMed ID: 28454487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions.
    Miller FH; Hammond N; Siddiqi AJ; Shroff S; Khatri G; Wang Y; Merrick LB; Nikolaidis P
    J Magn Reson Imaging; 2010 Jul; 32(1):138-47. PubMed ID: 20578020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
    Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T
    AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia.
    Cannella R; Rangaswamy B; Minervini MI; Borhani AA; Tsung A; Furlan A
    AJR Am J Roentgenol; 2019 Mar; 212(3):538-546. PubMed ID: 30557050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging.
    Zhu SC; Liu YH; Wei Y; Li LL; Dou SW; Sun TY; Shi DP
    World J Gastroenterol; 2018 Feb; 24(8):929-940. PubMed ID: 29491686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic Contrast Enhanced-MRI and Apparent Diffusion Coefficient Quantitation for Differentiate Hepatocellular Carcinoma from Hepatocellular Adenoma.
    Alareer HSN; Jasim Taher H; Dinar Abdullah A
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):931-937. PubMed ID: 38546075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion kurtosis imaging to assess response to treatment in hypervascular hepatocellular carcinoma.
    Goshima S; Kanematsu M; Noda Y; Kondo H; Watanabe H; Bae KT
    AJR Am J Roentgenol; 2015 May; 204(5):W543-9. PubMed ID: 25905960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion kurtosis imaging for differentiating between the benign and malignant sinonasal lesions.
    Jiang JX; Tang ZH; Zhong YF; Qiang JW
    J Magn Reson Imaging; 2017 May; 45(5):1446-1454. PubMed ID: 27758016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-flow haemangiomas versus hypervascular hepatocellular carcinoma showing "pseudo-washout" on gadoxetic acid-enhanced hepatic MRI: value of diffusion-weighted imaging in the differential diagnosis of small lesions.
    Nam SJ; Yu JS; Cho ES; Kim JH; Chung JJ
    Clin Radiol; 2017 Mar; 72(3):247-254. PubMed ID: 27789027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of hepatocellular carcinoma using apparent diffusion coefficient and diffusion kurtosis indices: preliminary experience in fresh liver explants.
    Rosenkrantz AB; Sigmund EE; Winnick A; Niver BE; Spieler B; Morgan GR; Hajdu CH
    Magn Reson Imaging; 2012 Dec; 30(10):1534-40. PubMed ID: 22819175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravoxel incoherent motion: application in differentiation of hepatocellular carcinoma and focal nodular hyperplasia.
    Luo M; Zhang L; Jiang XH; Zhang WD
    Diagn Interv Radiol; 2017; 23(4):263-271. PubMed ID: 28703102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of diffusion-weighted imaging for characterizing focal liver lesions.
    Parsai A; Zerizer I; Roche O; Gkoutzios P; Miquel ME
    Clin Imaging; 2015; 39(2):278-84. PubMed ID: 25433855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.